Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

CNS Pediatric Trials

North Carolina

CNS trials open to children and teens in North Carolina

14 CNS studies open to children and teens are recruiting participants at sites in 7 cities across North Carolina as of November 18, 2026, according to ClinicalTrials.gov.

Call (888) 927-9530
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every North Carolina city with a recruiting study

By research area: Migraine (5), ADHD (3), Depression (3), Epilepsy (2), Schizophrenia (1).

Durham (5), Chapel Hill (3), Charlotte (3), Greensboro (1), Kinston (1), Statesville (1), Winston-Salem (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

ADHD: recently updated in North Carolina

Basic details from each study's public record (the 12 most recently updated of 14). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

    • Phase 4
    • From 48 months, up to 69 months
    • All sexes
    Sponsor
    Supernus Pharmaceuticals, Inc.
    Recruiting in
    Durham
    Registry record
    NCT04781140 · updated
  2. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    • Observational
    • Ages 0 to 20
    • All sexes
    Sponsor
    Duke University
    Recruiting in
    Durham
    Registry record
    NCT04278404 · updated

Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in North Carolina on ClinicalTrials.gov.

Depression: recently updated in North Carolina

  1. TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

    • Observational
    • From 18 months, up to 11 years
    • All sexes
    Sponsor
    State University of New York at Buffalo
    Recruiting in
    Chapel Hill
    Registry record
    NCT07048574 · updated
  2. A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

    • Phase 3
    • Ages 12 to 17
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Recruiting in
    Chapel Hill
    Registry record
    NCT07227454 · updated

Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in North Carolina on ClinicalTrials.gov.

Epilepsy: recently updated in North Carolina

  1. ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

    • Phase 1/2
    • Ages 2 to 12
    • All sexes
    Sponsor
    Ionis Pharmaceuticals, Inc.
    Recruiting in
    Durham
    Registry record
    NCT07531745 · updated
  2. A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Encoded Therapeutics
    Recruiting in
    Durham
    Registry record
    NCT05419492 · updated

Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in North Carolina on ClinicalTrials.gov.

Migraine: recently updated in North Carolina

  1. Randomized Study in Children and Adolescents With Migraine: Acute Treatment

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Charlotte
    Registry record
    NCT04649242 · updated
  2. Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Charlotte
    Registry record
    NCT04743141 · updated
  3. A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Greensboro
    Registry record
    NCT05711394 · updated
  4. A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

    • Phase 1
    • Ages 6 to 11
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Statesville · Winston-Salem
    Registry record
    NCT06995729 · updated
  5. Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

    • Phase 3
    • Ages 6 to 17
    • All sexes
    Sponsor
    AbbVie
    Recruiting in
    Charlotte
    Registry record
    NCT05125302 · updated

Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in North Carolina on ClinicalTrials.gov.

Schizophrenia: recently updated in North Carolina

  1. Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

    • Phase 4
    • Ages 12 to 17
    • All sexes
    Sponsor
    Vanda Pharmaceuticals
    Recruiting in
    Kinston
    Registry record
    NCT05648591 · updated

Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in North Carolina on ClinicalTrials.gov.

Ask about studies in North Carolina

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that set an upper age limit, with at least half of the ages they accept under 18, as each study is coded in the registry.

CNS Pediatric Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-9530

or send a short form

This form is for adults. If you are under 18, please ask a parent or legal guardian to contact us.

How should we reach you?

Call